IDEAYA Biosciences (IDYA) EBIT Margin (2020 - 2025)
Historic EBIT Margin for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to 869.53%.
- IDEAYA Biosciences' EBIT Margin rose 11895900.0% to 869.53% in Q4 2025 from the same period last year, while for Dec 2025 it was 90.14%, marking a year-over-year increase of 45809300.0%. This contributed to the annual value of 72.84% for FY2025, which is 45982300.0% up from last year.
- Per IDEAYA Biosciences' latest filing, its EBIT Margin stood at 869.53% for Q4 2025, which was up 11895900.0% from 52.18% recorded in Q3 2025.
- Over the past 5 years, IDEAYA Biosciences' EBIT Margin peaked at 52.18% during Q3 2025, and registered a low of 2059.11% during Q4 2024.
- Moreover, its 5-year median value for EBIT Margin was 384.53% (2022), whereas its average is 519.11%.
- In the last 5 years, IDEAYA Biosciences' EBIT Margin tumbled by -9903500bps in 2024 and then surged by 11895900bps in 2025.
- Over the past 5 years, IDEAYA Biosciences' EBIT Margin (Quarter) stood at 620.16% in 2021, then fell by -6bps to 657.46% in 2022, then crashed by -63bps to 1068.77% in 2023, then tumbled by -93bps to 2059.11% in 2024, then surged by 58bps to 869.53% in 2025.
- Its EBIT Margin was 869.53% in Q4 2025, compared to 52.18% in Q3 2025 and 2059.11% in Q4 2024.